Skip to main content
. 2020 Sep 29;35(1):e23578. doi: 10.1002/jcla.23578

Figure 1.

Figure 1

Low miR‐488 expression suggested poor prognosis of colorectal cancer (CRC) patients after chemotherapy. A, MiR‐488 expression was compared between CRC patients with recurrence/metastasis and patients without recurrence/metastasis. *: P < .05. B, High (>mean) miR‐488 expression was associated with more favorable 3‐y survival of CRC patients than lowly expressed miR‐488